Previous Close | 43.09 |
Open | 42.45 |
Bid | 43.46 x 100 |
Ask | 43.63 x 100 |
Day's Range | 41.71 - 43.81 |
52 Week Range | 19.01 - 47.74 |
Volume | |
Avg. Volume | 694,437 |
Market Cap | 3.252B |
Beta (5Y Monthly) | 0.80 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.96 |
Earnings Date | May 07, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 53.00 |
Comparative Analysis of Q1 Earnings Against Analyst Expectations and Future Projections
IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, provided a business update, and announced financial results for the first quarter ended March 31, 2024.
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in an upcoming investor relations event.